Sinofn Health Sinofn Health

OEM SINOFN Private Label Food Supplements Supplier & Factory

Scientific Innovation | Precision Manufacturing | Global Supply Chain Solutions

šŸ”¬About SINOFN: Science-Driven OEM Excellence

SINOFN Health Co., Ltd. represents the evolution of contract manufacturing. Founded in 2012 with roots deep in the Chinese Academy of Sciences (CAS), we bridge the gap between academic research and commercial scalability. We don't just manufacture supplements; we engineer health solutions.

Our commitment to E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness) is evidenced by our deep-tech R&D centers and our legacy in treating metabolic disorders. By leveraging our 2025 Shanghai operational hub, we provide global brands with a strategic partner that understands the nuances of global compliance and bioavailability.

šŸ“ˆIndustry Trends & Macro Strategy

Personalized Nutrition

The "one-size-fits-all" supplement model is obsolete. At SINOFN, we are at the forefront of personalized formulation, utilizing biomarkers to guide ingredient ratios for niche demographics.

Clean Label & Transparency

Modern consumers demand total traceability. We utilize blockchain-enabled batch tracking from raw material intake to final retail packaging, ensuring unwavering brand integrity.

Bioavailability Optimization

Superior ingredient sourcing is only half the battle. Our R&D team focuses on delivery systems—liposomal, time-release, and peptide-bonded—to ensure maximum nutrient absorption.

šŸš€Technology Roadmap & R&D Power

Our innovation ecosystem is built on a "Triple Helix" model: Academic Research (CAS), Clinical Application (Medical Nutrition), and Industrial Production (GMP Factories). Led by Dr. Tan Shengjie and Dr. Zhang Ying, we continuously pivot our R&D roadmap to address emerging health concerns, from cognitive performance to metabolic health.

53k 掔Facility Area
25+Patents
71+Trademarks
500M+Annual Capacity

ā“Frequently Asked Questions

Q: Does SINOFN support rapid prototyping for startups?

Yes. We operate specialized pilot-scale prototyping lines that allow brands to test small-batch runs before scaling to mass production, minimizing financial risk.

Q: How do you handle cross-border regulatory compliance?

Our regulatory affairs department specializes in navigating complex frameworks including FDA (USA), EFSA (Europe), and TGA (Australia) standards, ensuring your private label products are market-ready.

Q: What is the significance of the CAS partnership?

Being backed by the Chinese Academy of Sciences gives us exclusive access to cutting-edge research on bioactive compounds, differentiating our products from generic off-the-shelf formulations.